Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials
View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter
Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.
By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]